About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Massachusetts General Hospital Cancer Center
https://www.massgeneral.org/cancer-center
Changing Updates in Hematologic Malignancies
Grand Rounds
Videos
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
ASCO 2021 Highlights From GEOMETRY mono-1 Study on Advanced NSCLC: Capmatinib in METex14 or MET-Amplified Disease
By
Massachusetts General Hospital Cancer Center
FEATURING
Rebecca Heist
By
Massachusetts General Hospital Cancer Center
FEATURING
Rebecca Heist
29 views
July 6, 2021
0 Comments
Login to view comments.
Click here to Login
Videos
11:21
Massachusetts General Hospital Cancer Center
Uveal Melanoma for Community Oncologists
Feat.
K. Montazeri
14:06
Insights from 2023 Society for Melanoma Research Annual Meeting
2023 SMR Congress Insights: "Time-to-Event Machine Learning Pre…
Feat.
Y. Semenov
18:31
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: CAR/BsAb Toxicity in MM - Prevention, Treatment, and Surv…
Feat.
N. S. Raje
10:42
Insights from 2023 EHA® Annual Meeting
Updated Data for Ziftomenib in Adults With NPM1-Mutated R/R AML
Feat.
A. Fathi
06:25
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Phase 1/2 TRIDENT-1 Trial - Intracranial …
Feat.
J. Lin
16:49
Massachusetts General Hospital Cancer Center
ESR1 Mutations in HR+/HER2- mBC and Their Role in Treatment Outcomes
Feat.
S. Wander
17:54
Massachusetts General Hospital Cancer Center
Genetic Heterogeneity in Brain Metastases and Implications for Clini…
Feat.
P. Brastianos
09:52
Massachusetts General Hospital Cancer Center
Maintenance Therapy in AML: Protecting Remission, Extending Survival…
Feat.
A. Brunner
08:20
Massachusetts General Hospital Cancer Center
ESMO 2021 Updates on 1L DKN-01 + Tislelizumab & Chemotherapy in …
Feat.
S. Klempner
12:08
Massachusetts General Hospital Cancer Center
Selpercatinib Efficacy & Safety in Patients With RET-Altered Thy…
Feat.
L. Wirth
10:05
i3 Health
Emerging Treatment Strategies for Advanced Cholangiocarcinoma: Molec…
Feat.
L. Goyal
50:37
Massachusetts General Hospital Cancer Center
Next Steps in FGFRi in Cholangiocarcinoma: FGFR Pathway & Curren…
Feat.
L. Goyal
04:27
Massachusetts General Hospital Cancer Center
ASCO 2021 Highlights From GEOMETRY mono-1 Study on Advanced NSCLC: C…
Feat.
R. Heist
16:46
Virtual West Oncology Conference
2021 Updates on mTNBC: Do Olaparib/Talazoparib Improve PFS Compared …
Feat.
N. Vidula
18:15
CancerGRACE
Targeted Therapy for EGFR+ NSCLC: What Are the Current Options Upon …
Feat.
Z. Piotrowska
10:33
GRACE
Targeted Therapy for EGFR+ NSCLC: How Do We Think About Acquired Res…
Feat.
Z. Piotrowska
31:44
Massachusetts General Hospital Cancer Center
Tumor Infiltrating Lymphocytes: What Is the Data That Supports the P…
Feat.
K. Flaherty
13:52
2020 ASCO Virtual Direct™ Highlights
Targeting Exon 20 Insertions in NSCLC: Anti-Tumor Activity With T-Dx…
Feat.
I. Dagogo-Jack
05:44
2020 Virtual ESMO Review
2020 ESMO Update on Targeted Therapy in NSCLC: Can We Safely Combine…
Feat.
I. Dagogo-Jack
07:33
2020 Virtual ESMO Review
2020 ESMO Update on Targeted Therapy in NSCLC: Does ADAURA Trial Sug…
Feat.
I. Dagogo-Jack
07:14
ecancer
2020 ESMO Update on ADCs in mTNBC: Is Sacituzumab Govitecan More Ben…
Feat.
A. Bardia
13:34
2020 Virtual ESMO Review
2020 ESMO Update on Targeted Therapy in NSCLC: Can We Safely Combine…
Feat.
I. Dagogo-Jack
26:39
Virtual Diversity in Cancer Care
Risk Factors in Lung Cancer: Which Risk Factor Is Predominant? How I…
Feat.
I. Dagogo-Jack